DEFERRED TREATMENT OF LOCALLY ADVANCED NONMETASTATIC PROSTATE CANCER: A LONG-TERM FOLLOWUP
- 1 February 1999
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 161 (2), 505-508
- https://doi.org/10.1016/s0022-5347(01)61936-0
Abstract
Purpose: We prospectively investigated long-term survival in select men with locally advanced, nonmetastatic prostate cancer managed with deferred treatment. Materials and Methods: A total of 50 patients with prostate cancer clinically outside the prostatic capsule and without distant metastases were included in a surveillance protocol. The men were treated if and when symptoms occurred or upon request. The series was followed until December 1994. No patient was lost to followup. Results: Median patient age at diagnosis was 71 years. All patients were followed more than 144 months or died before then. Actual (cumulative incidence) overall and disease specific survival rates at 5, 10 and 12 years were 68 and 90, 34 and 74, and 26 and 70%, respectively. A third of the patients had not received antitumor treatment at followup or before death. Conclusions: When managed with deferred treatment nonpoorly differentiated, locally advanced nonmetastatic prostate cancer seems to have a poorer survival outcome than similarly managed clinically localized prostate cancer. However, compared with other treatments and in terms of survival deferred treatment may be an option for select patients with such tumors and a life expectancy of 10 years or less.Keywords
This publication has 13 references indexed in Scilit:
- Deferred treatment of clinically localized low-grade prostate cancer: Actual 10-year and projected 15-year follow-up of the karolinska seriesUrology, 1997
- Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinNew England Journal of Medicine, 1997
- Fifteen-year survival in prostate cancer. A prospective, population-based study in SwedenPublished by American Medical Association (AMA) ,1997
- The Swedish prostate cancer paradoxPublished by American Medical Association (AMA) ,1997
- Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology groupUrology, 1995
- Surgically staged patients with prostatic carcinoma treated with definitive radiotherapy: fifteen-year resultsUrology, 1994
- Localised prostatic cancer: management and detection issuesThe Lancet, 1994
- Carcinoma of the prostate: Results of radical radiotherapy (1970–1985)International Journal of Radiation Oncology*Biology*Physics, 1993
- Comparison of transrectal prostate digital aspiration and ultrasound-guided core biopsies in 99 menUrology, 1991
- Cytologic Malignancy Grading of Prostatic Carcinoma by Transrectal Aspiration Biopsy:A Five-year Follow-up Study of 469 Hormone-treated PatientsScandinavian Journal of Urology and Nephrology, 1971